Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma

Background/Aims: Kidney renal clear cell carcinoma (KIRC) is one of the most fatal malignancies due to late diagnosis and poor treatment. To improve its prognosis, a screening for molecular biomarkers of KIRC is urgently needed. Long non-coding RNAs (lncRNAs) play important roles in tumorigenesis an...

Full description

Bibliographic Details
Main Authors: Jukun Song, Juxiang Peng, Chen Zhu, Guohui Bai, Yongda Liu, Jianguo Zhu, Jianguo Liu
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2018-08-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:https://www.karger.com/Article/FullText/492699
_version_ 1811282921168830464
author Jukun Song
Juxiang Peng
Chen Zhu
Guohui Bai
Yongda Liu
Jianguo Zhu
Jianguo Liu
author_facet Jukun Song
Juxiang Peng
Chen Zhu
Guohui Bai
Yongda Liu
Jianguo Zhu
Jianguo Liu
author_sort Jukun Song
collection DOAJ
description Background/Aims: Kidney renal clear cell carcinoma (KIRC) is one of the most fatal malignancies due to late diagnosis and poor treatment. To improve its prognosis, a screening for molecular biomarkers of KIRC is urgently needed. Long non-coding RNAs (lncRNAs) play important roles in tumorigenesis and prognosis of cancers. However, it is not clear whether lncRNAs can be used as molecular biomarkers in predicting the survival of KIRC patients. Methods: In this study, our aim was to identify lncRNAs/mRNAs signatures and their prognostic values in KIRC. The aberrant expression profile of mRNAs and lncRNAs in 529 KIRC tissues and 72 adjacent non-tumor pancreatic tissues were obtained from the Cancer Genome Atlas (TCGA). A weighted gene co-expression network analysis (WGCNA) of two key lncRNAs was constructed. We constructed an aberrant lncRNA-mRNA-miRNA ceRNA network in CESC. In addition, Gene Ontology (GO) and KEGG pathway analysis were performed. Results: Using lncRNA/mRNA expression profiling data, the overall analysis revealed that two novel lncRNA signatures (DNM1P35 and MIR155HG) and several mRNAs were found to be significantly correlated with KIRC patient’s overall analysis. Based on the target gene of the two lncRNA in co-expression network, the GO and KEGG analysis were also performed. A dysregulated lncRNA-related ceRNA network was also observed. Conclusion: These results suggested that the two novel lncRNAs signatures may act as independent prognostic biomarkers for predicting the survival of KIRC patient.
first_indexed 2024-04-13T02:01:14Z
format Article
id doaj.art-13e528e94afc4f47924963dad8ee0134
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-04-13T02:01:14Z
publishDate 2018-08-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-13e528e94afc4f47924963dad8ee01342022-12-22T03:07:36ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782018-08-014862549256210.1159/000492699492699Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell CarcinomaJukun SongJuxiang PengChen ZhuGuohui BaiYongda LiuJianguo ZhuJianguo LiuBackground/Aims: Kidney renal clear cell carcinoma (KIRC) is one of the most fatal malignancies due to late diagnosis and poor treatment. To improve its prognosis, a screening for molecular biomarkers of KIRC is urgently needed. Long non-coding RNAs (lncRNAs) play important roles in tumorigenesis and prognosis of cancers. However, it is not clear whether lncRNAs can be used as molecular biomarkers in predicting the survival of KIRC patients. Methods: In this study, our aim was to identify lncRNAs/mRNAs signatures and their prognostic values in KIRC. The aberrant expression profile of mRNAs and lncRNAs in 529 KIRC tissues and 72 adjacent non-tumor pancreatic tissues were obtained from the Cancer Genome Atlas (TCGA). A weighted gene co-expression network analysis (WGCNA) of two key lncRNAs was constructed. We constructed an aberrant lncRNA-mRNA-miRNA ceRNA network in CESC. In addition, Gene Ontology (GO) and KEGG pathway analysis were performed. Results: Using lncRNA/mRNA expression profiling data, the overall analysis revealed that two novel lncRNA signatures (DNM1P35 and MIR155HG) and several mRNAs were found to be significantly correlated with KIRC patient’s overall analysis. Based on the target gene of the two lncRNA in co-expression network, the GO and KEGG analysis were also performed. A dysregulated lncRNA-related ceRNA network was also observed. Conclusion: These results suggested that the two novel lncRNAs signatures may act as independent prognostic biomarkers for predicting the survival of KIRC patient.https://www.karger.com/Article/FullText/492699Long non-coding RNAsKidney Renal ClearCell CarcinomaCompetitive endogenous RNA
spellingShingle Jukun Song
Juxiang Peng
Chen Zhu
Guohui Bai
Yongda Liu
Jianguo Zhu
Jianguo Liu
Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma
Cellular Physiology and Biochemistry
Long non-coding RNAs
Kidney Renal Clear
Cell Carcinoma
Competitive endogenous RNA
title Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma
title_full Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma
title_fullStr Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma
title_full_unstemmed Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma
title_short Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma
title_sort identification and validation of two novel prognostic lncrnas in kidney renal clear cell carcinoma
topic Long non-coding RNAs
Kidney Renal Clear
Cell Carcinoma
Competitive endogenous RNA
url https://www.karger.com/Article/FullText/492699
work_keys_str_mv AT jukunsong identificationandvalidationoftwonovelprognosticlncrnasinkidneyrenalclearcellcarcinoma
AT juxiangpeng identificationandvalidationoftwonovelprognosticlncrnasinkidneyrenalclearcellcarcinoma
AT chenzhu identificationandvalidationoftwonovelprognosticlncrnasinkidneyrenalclearcellcarcinoma
AT guohuibai identificationandvalidationoftwonovelprognosticlncrnasinkidneyrenalclearcellcarcinoma
AT yongdaliu identificationandvalidationoftwonovelprognosticlncrnasinkidneyrenalclearcellcarcinoma
AT jianguozhu identificationandvalidationoftwonovelprognosticlncrnasinkidneyrenalclearcellcarcinoma
AT jianguoliu identificationandvalidationoftwonovelprognosticlncrnasinkidneyrenalclearcellcarcinoma